Cargando…

A moderate 500-m treadmill walk for estimating peak oxygen uptake in men with NYHA class I-II heart failure and reduced left ventricular ejection fraction

BACKGROUND: Maximal cardiopulmonary exercise testing (CPX) is the gold-standard for cardiorespiratory fitness assessment in chronic heart failure (CHF) patients. However, high costs, required medical supervision, and safety concerns make maximal exercise testing impractical for evaluating mobility-i...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazzoni, Gianni, Sassone, Biagio, Pasanisi, Giovanni, Myers, Jonathan, Mandini, Simona, Volpato, Stefano, Conconi, Francesco, Chiaranda, Giorgio, Grazzi, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902976/
https://www.ncbi.nlm.nih.gov/pubmed/29661150
http://dx.doi.org/10.1186/s12872-018-0801-9
_version_ 1783314856078737408
author Mazzoni, Gianni
Sassone, Biagio
Pasanisi, Giovanni
Myers, Jonathan
Mandini, Simona
Volpato, Stefano
Conconi, Francesco
Chiaranda, Giorgio
Grazzi, Giovanni
author_facet Mazzoni, Gianni
Sassone, Biagio
Pasanisi, Giovanni
Myers, Jonathan
Mandini, Simona
Volpato, Stefano
Conconi, Francesco
Chiaranda, Giorgio
Grazzi, Giovanni
author_sort Mazzoni, Gianni
collection PubMed
description BACKGROUND: Maximal cardiopulmonary exercise testing (CPX) is the gold-standard for cardiorespiratory fitness assessment in chronic heart failure (CHF) patients. However, high costs, required medical supervision, and safety concerns make maximal exercise testing impractical for evaluating mobility-impaired adults. Thus, several submaximal walking protocols have been developed and currently used to estimate peak oxygen consumption (VO(2)peak) in CHF patients. However, these tests have to be performed at close to maximum exercise intensity. The aim of this study was to examine the validity of a 500-m treadmill-walking test carried out at moderate intensity for estimating VO(2)peak in community-dwelling adult and elderly patients with CHF and reduced left ventricular ejection fraction (HFrEF). METHODS: Forty-three clinically stable men with HFrEF (age 67.7 ± 9.2 years, and left ventricular ejection fraction, LVEF 38% ± 6%) underwent exercise testing during an outpatient cardiac rehabilitation/secondary prevention program. Each patients completed a CPX, and a moderate and self-paced (11–13/20 on the Borg scale) 500-m treadmill-walking test. Age, weight, height, walk time, and heart rate during the 500-m test were entered into prediction equations previously validated for VO(2)peak estimation from a 1000-m walking test in patients with cardiovascular disease and preserved LVEF. RESULTS: Directly measured and estimated VO(2)peak values were not different (21.6 ± 4.9 vs 21.7 ± 4.6 mL/kg/min). The comparison between measured and estimated VO(2)peak values yielded a correlation of R = 0.97 (SEE = 0.7 mL/kg/min, P < 0.0001). The slope and the intercept coincided with the line of identity (Passing and Bablock analysis, P = 0.50). Residuals were normally distributed, and the examination of the Bland-Altman analysis do not show systematic or proportional error. CONCLUSIONS: A moderate and self-regulated 500-m treadmill-walking test is a valid tool for VO(2)peak estimation in patients with HFrEF. These findings may have practical implications in the context of transitioning from clinically based programs to fitness facilities or self-guided exercise programs in adults and elderly men with HFrEF. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12872-018-0801-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5902976
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59029762018-04-23 A moderate 500-m treadmill walk for estimating peak oxygen uptake in men with NYHA class I-II heart failure and reduced left ventricular ejection fraction Mazzoni, Gianni Sassone, Biagio Pasanisi, Giovanni Myers, Jonathan Mandini, Simona Volpato, Stefano Conconi, Francesco Chiaranda, Giorgio Grazzi, Giovanni BMC Cardiovasc Disord Research Article BACKGROUND: Maximal cardiopulmonary exercise testing (CPX) is the gold-standard for cardiorespiratory fitness assessment in chronic heart failure (CHF) patients. However, high costs, required medical supervision, and safety concerns make maximal exercise testing impractical for evaluating mobility-impaired adults. Thus, several submaximal walking protocols have been developed and currently used to estimate peak oxygen consumption (VO(2)peak) in CHF patients. However, these tests have to be performed at close to maximum exercise intensity. The aim of this study was to examine the validity of a 500-m treadmill-walking test carried out at moderate intensity for estimating VO(2)peak in community-dwelling adult and elderly patients with CHF and reduced left ventricular ejection fraction (HFrEF). METHODS: Forty-three clinically stable men with HFrEF (age 67.7 ± 9.2 years, and left ventricular ejection fraction, LVEF 38% ± 6%) underwent exercise testing during an outpatient cardiac rehabilitation/secondary prevention program. Each patients completed a CPX, and a moderate and self-paced (11–13/20 on the Borg scale) 500-m treadmill-walking test. Age, weight, height, walk time, and heart rate during the 500-m test were entered into prediction equations previously validated for VO(2)peak estimation from a 1000-m walking test in patients with cardiovascular disease and preserved LVEF. RESULTS: Directly measured and estimated VO(2)peak values were not different (21.6 ± 4.9 vs 21.7 ± 4.6 mL/kg/min). The comparison between measured and estimated VO(2)peak values yielded a correlation of R = 0.97 (SEE = 0.7 mL/kg/min, P < 0.0001). The slope and the intercept coincided with the line of identity (Passing and Bablock analysis, P = 0.50). Residuals were normally distributed, and the examination of the Bland-Altman analysis do not show systematic or proportional error. CONCLUSIONS: A moderate and self-regulated 500-m treadmill-walking test is a valid tool for VO(2)peak estimation in patients with HFrEF. These findings may have practical implications in the context of transitioning from clinically based programs to fitness facilities or self-guided exercise programs in adults and elderly men with HFrEF. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12872-018-0801-9) contains supplementary material, which is available to authorized users. BioMed Central 2018-04-16 /pmc/articles/PMC5902976/ /pubmed/29661150 http://dx.doi.org/10.1186/s12872-018-0801-9 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Mazzoni, Gianni
Sassone, Biagio
Pasanisi, Giovanni
Myers, Jonathan
Mandini, Simona
Volpato, Stefano
Conconi, Francesco
Chiaranda, Giorgio
Grazzi, Giovanni
A moderate 500-m treadmill walk for estimating peak oxygen uptake in men with NYHA class I-II heart failure and reduced left ventricular ejection fraction
title A moderate 500-m treadmill walk for estimating peak oxygen uptake in men with NYHA class I-II heart failure and reduced left ventricular ejection fraction
title_full A moderate 500-m treadmill walk for estimating peak oxygen uptake in men with NYHA class I-II heart failure and reduced left ventricular ejection fraction
title_fullStr A moderate 500-m treadmill walk for estimating peak oxygen uptake in men with NYHA class I-II heart failure and reduced left ventricular ejection fraction
title_full_unstemmed A moderate 500-m treadmill walk for estimating peak oxygen uptake in men with NYHA class I-II heart failure and reduced left ventricular ejection fraction
title_short A moderate 500-m treadmill walk for estimating peak oxygen uptake in men with NYHA class I-II heart failure and reduced left ventricular ejection fraction
title_sort moderate 500-m treadmill walk for estimating peak oxygen uptake in men with nyha class i-ii heart failure and reduced left ventricular ejection fraction
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902976/
https://www.ncbi.nlm.nih.gov/pubmed/29661150
http://dx.doi.org/10.1186/s12872-018-0801-9
work_keys_str_mv AT mazzonigianni amoderate500mtreadmillwalkforestimatingpeakoxygenuptakeinmenwithnyhaclassiiiheartfailureandreducedleftventricularejectionfraction
AT sassonebiagio amoderate500mtreadmillwalkforestimatingpeakoxygenuptakeinmenwithnyhaclassiiiheartfailureandreducedleftventricularejectionfraction
AT pasanisigiovanni amoderate500mtreadmillwalkforestimatingpeakoxygenuptakeinmenwithnyhaclassiiiheartfailureandreducedleftventricularejectionfraction
AT myersjonathan amoderate500mtreadmillwalkforestimatingpeakoxygenuptakeinmenwithnyhaclassiiiheartfailureandreducedleftventricularejectionfraction
AT mandinisimona amoderate500mtreadmillwalkforestimatingpeakoxygenuptakeinmenwithnyhaclassiiiheartfailureandreducedleftventricularejectionfraction
AT volpatostefano amoderate500mtreadmillwalkforestimatingpeakoxygenuptakeinmenwithnyhaclassiiiheartfailureandreducedleftventricularejectionfraction
AT conconifrancesco amoderate500mtreadmillwalkforestimatingpeakoxygenuptakeinmenwithnyhaclassiiiheartfailureandreducedleftventricularejectionfraction
AT chiarandagiorgio amoderate500mtreadmillwalkforestimatingpeakoxygenuptakeinmenwithnyhaclassiiiheartfailureandreducedleftventricularejectionfraction
AT grazzigiovanni amoderate500mtreadmillwalkforestimatingpeakoxygenuptakeinmenwithnyhaclassiiiheartfailureandreducedleftventricularejectionfraction
AT mazzonigianni moderate500mtreadmillwalkforestimatingpeakoxygenuptakeinmenwithnyhaclassiiiheartfailureandreducedleftventricularejectionfraction
AT sassonebiagio moderate500mtreadmillwalkforestimatingpeakoxygenuptakeinmenwithnyhaclassiiiheartfailureandreducedleftventricularejectionfraction
AT pasanisigiovanni moderate500mtreadmillwalkforestimatingpeakoxygenuptakeinmenwithnyhaclassiiiheartfailureandreducedleftventricularejectionfraction
AT myersjonathan moderate500mtreadmillwalkforestimatingpeakoxygenuptakeinmenwithnyhaclassiiiheartfailureandreducedleftventricularejectionfraction
AT mandinisimona moderate500mtreadmillwalkforestimatingpeakoxygenuptakeinmenwithnyhaclassiiiheartfailureandreducedleftventricularejectionfraction
AT volpatostefano moderate500mtreadmillwalkforestimatingpeakoxygenuptakeinmenwithnyhaclassiiiheartfailureandreducedleftventricularejectionfraction
AT conconifrancesco moderate500mtreadmillwalkforestimatingpeakoxygenuptakeinmenwithnyhaclassiiiheartfailureandreducedleftventricularejectionfraction
AT chiarandagiorgio moderate500mtreadmillwalkforestimatingpeakoxygenuptakeinmenwithnyhaclassiiiheartfailureandreducedleftventricularejectionfraction
AT grazzigiovanni moderate500mtreadmillwalkforestimatingpeakoxygenuptakeinmenwithnyhaclassiiiheartfailureandreducedleftventricularejectionfraction